All terms in GO

Label Id Description
peptidyl-threonine O-acetylation GO_0120258 [The acetylation of peptidyl-threonine to form peptidyl-O-acetyl-L-threonine.]
peptidyl-threonine acetylation GO_0120257 [The acetylation of peptidyl-threonine.]
peptidyl-threonine modification GO_0018210 [The modification of peptidyl-threonine.]
obsolete positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in positive regulation of G2/M transition of mitotic cell cycle GO_1904993 [OBSOLETE. Any positive regulation of cyclin-dependent protein serine/threonine kinase activity that is involved in positive regulation of G2/M transition of mitotic cell cycle.]
response to aromatase inhibitor GO_0061477 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aromatase inhibitor stimulus.]
positive regulation of leukocyte adhesion to vascular endothelial cell GO_1904996 [Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.]
response to anticoagulant GO_0061476 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anticoagulant stimulus.]
negative regulation of leukocyte adhesion to vascular endothelial cell GO_1904995 [Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell.]
cytosolic valyl-tRNA aminoacylation GO_0061475 [The process of coupling valine to valyl-tRNA in the cytosol, catalyzed by valyl-tRNA synthetase. In tRNA aminoacylation, the amino acid is first activated by linkage to AMP and then transferred to either the 2'- or the 3'-hydroxyl group of the 3'-adenosine residue of the tRNA.]
negative regulation of leukocyte adhesion to arterial endothelial cell GO_1904998 [Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.]
regulation of leukocyte adhesion to arterial endothelial cell GO_1904997 [Any process that modulates the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.]
positive regulation of leukocyte adhesion to arterial endothelial cell GO_1904999 [Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to arterial endothelial cell.]
response to reverse transcriptase inhibitor GO_0061479 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reverse transcriptase inhibitor stimulus.]
T follicular helper cell differentiation GO_0061470 [The process in which a relatively unspecialized T cell acquires specialized features of a mature T follicular helper cell.]
phagolysosome membrane GO_0061474 [The lipid bilayer surrounding a phagolysosome.]
murein tripeptide carboxypeptidase activity GO_0061473 [Catalysis of the reaction: L-alanyl-gamma-D-glutamyl-meso-diaminoheptanedioate (murein tripeptide) + H2O = L-alanyl-D-glutamate + meso-2,6-diaminoheptanedioate.]
karyomere membrane fusion GO_0061472 [Process whereby karyomere membranes fuse during interphase to form a single lobed nucleus.]
karyomere assembly GO_0061471 [The process where the nuclear membrane engulfs condensed chromosomes to form karyomeres during M phase of the mitotic cell cycle.]
7SK snRNP GO_0120259 [A ribonucleoprotein complex that contains the 7SK snRNA. The 7SK snRNP plays a central role in RNA polymerase II elongation control by regulating the availability of active P-TEFb.]
GO_0061489 GO_0061489